Vaccine development
Bill Gates: The Visionary Who Changed the World
Bill Gates, one of the most recognized names in the world of technology and philanthropy, is a man whose influence extends far beyond...
Stéphane Bancel: Leading Moderna’s Evolution and Innovation
Stéphane Bancel, born on July 20, 1972, in Marseille, France, has emerged as a pivotal figure in the biotechnology sector. Currently serving as...
Moderna Stock Plunges as Company Slashes 2025 Revenue Forecast and Announces Major Cost Cuts
Moderna (NASDAQ: MRNA) shares tumbled 18% in premarket trading on Monday after the biotechnology company significantly lowered its 2025 revenue forecast and announced...
Stéphane Bancel: The Visionary Leader Behind Moderna’s Revolution
Stéphane Bancel is one of the most transformative figures in modern biotechnology, known for his pivotal role as the CEO of Moderna, the...
Ugur Sahin: A Visionary Scientist Behind Revolutionary Medicine
Ugur Sahin, a name now synonymous with groundbreaking advancements in biotechnology, has become a globally recognized figure due to his pivotal role in...
The Life and Legacy of Patrick Soon-Shiong: A Trailblazer in Medicine and Business
Patrick Soon-Shiong is a renowned medical doctor, entrepreneur, and philanthropist whose groundbreaking work in the fields of cancer treatment, biotechnology, and healthcare has...
Thomas Strüngmann & Family: A Legacy of Innovation in Pharmaceuticals and Investment
Thomas Strüngmann, a name that resonates with success and foresight in the pharmaceutical and investment industries, is an influential figure whose achievements have...
Andreas Strüngmann & Family: A Legacy in Pharmaceuticals and Technology
Andreas Strüngmann, a name that is synonymous with success in the pharmaceutical and technology industries, is one of Germany’s wealthiest and most influential...
Jiang Rensheng & Family: A Journey of Innovation and Business Leadership
Jiang Rensheng, a prominent Chinese entrepreneur, is widely recognized for his significant contributions to the business landscape, particularly in the fields of healthcare...
FDA Panel Backs New COVID Vaccines for JN.1 Variant by Fall
An expert panel from the Food and Drug Administration (FDA) voted unanimously on Wednesday to develop new COVID-19 vaccines specifically targeting the JN.1...
